Fresenius Kabi in talks to buy Akorn

By Gareth Macdonald contact

- Last updated on GMT

iStock/macgyverhh
iStock/macgyverhh

Related tags: U.s. securities and exchange commission, Fresenius kabi

Akorn Inc is in takeover talks with German injectable drug specialist Fresenius SE & Co. KGaA.

The US generic drug manufacturer confirmed the talks in a US Securities and Exchange Commission (SEC) filing​ today.

Similarly, Fresenius said​ discussions are ongoing.

A spokesman for the German firm told us "Fresenius Kabi is currently in discussions with Akorn, Inc. concerning a potential acquisition​."

He declined to comment further.

Related news

Show more

Follow us

Products

View more

Webinars